-
Liraglutide CAS 204656-20-2Liraglutide is a GLP-1 receptor agonist peptide active pharmaceutical ingredient (API). Supplied by Shaoxing Hantai, it meets international quality standards with stable and reliable quality. Withread more
-
Azithromycin CAS 83905‑01‑5Azithromycin is a semisynthetic macrolide antibiotic active pharmaceutical ingredient (API). Supplied by Shaoxing Hantai, it meets international pharmacopoeia standards with stable and reliableread more
-
Pizotifen Malate CAS 5189-11-7Pizotifen malate is a serotonin receptor antagonist active pharmaceutical ingredient (API) for migraine prophylaxis. Supplied by Shaoxing Hantai, it complies with international pharmacopoeiaread more
-
Resmetirom CAS 920509-32-6Resmetirom is a selective thyroid hormone receptor beta (THR-β) agonist active pharmaceutical ingredient (API) for liver diseases. Supplied by Shaoxing Hantai, it meets international pharmacopoeiaread more
-
Baxdrostat CAS 1428652-17-8Baxdrostat is a highly selective aldosterone synthase inhibitor active pharmaceutical ingredient (API) for cardiovascular use. Supplied by Shaoxing Hantai, it meets international pharmacopoeiaread more
-
Osimertinib Mesylate CAS 1421373-66-1Osimertinib mesylate is a third-generation EGFR-TKI active pharmaceutical ingredient (API) for oncology. Supplied by Shaoxing Hantai, it meets international pharmacopoeia standards with stable andread more
-
Palbociclib CAS 571190-30-2Palbociclib is a selective CDK4/6 inhibitor active pharmaceutical ingredient (API) for oncology. Supplied by Shaoxing Hantai, it complies with international pharmacopoeia standards with stableread more
-
Rimegepant Sulfate CAS 1374024-48-2Rimegepant sulfate is a small-molecule CGRP receptor antagonist active pharmaceutical ingredient (API) for migraine. Supplied by Shaoxing Hantai, it meets international pharmacopoeia standards withread more
-
Upadacitinib Hemihydrate CAS 2050057-56-0Upadacitinib is a selective JAK1 inhibitor active pharmaceutical ingredient (API) for immunomodulation. Supplied by Shaoxing Hantai, it meets international pharmacopoeia standards with stable andread more
Dec 10, 2020 · Liraglutide is contraindicated in patients with a personal or family history of MTC and in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Counsel patients...
Jul 04, 2022 · Use liraglutide (saxenda) as ordered by your doctor. Read all information given to you. Follow all instructions closely. It is given as a shot into the fatty part of the skin on the top...
Nov 05, 2021 · Serious side effects of Liraglutide include: hives , fast heartbeats, dizziness, trouble breathing , difficulty swallowing, swelling of the face, lips, tongue, or throat , racing or...
Liraglutide is a GLP-1R agonist which was approved by the FDA as a once-daily injection for the treatment of T2DM in 2010 and for obesity in 2014. It has 97% homology to human GLP-1 (7...
Liraglutide 3.0 mg was approved by the US FDA in December 2014. Liraglutide is a GLP-1 receptor agonist that has been used for type 2 diabetes in doses up to 1.8 mg. In animal...
Liraglutide – Liraglutide is a glucagon-like peptide-1 agonist that was approved for weight loss by the FDA in 2014. Emerging data indicates liraglutide may be safe and effective … Obesity in...
